BioSpace News Archive

Deals

Cresco Labs to Acquire Origin House in Largest-Ever Public Company Acquisition in the U.S. Cannabis Sector

Solidifies a Leading Position in California, the World’s Largest Regulated Cannabis Market

April 1, 2019
·
15 min read
Business

AccuReg Appoints Veteran Chief Marketing Officer

David Peterson joins AccuReg with more than 20 years of healthcare and technology marketing experience

April 1, 2019
·
2 min read
BioCapital

Experimental Biology Highlights - Cancer, Neurodegenerative Diseases And Medical News

Studies offer insights on development, prevention and treatment of leading diseases

April 1, 2019
·
2 min read
Lone Star Bio

Smart speaker technology harnessed for hospital medical treatments

Smart speakers, such as the Amazon Echo and Google Home, offer a conversational voice interface that allows interventional radiology physicians to ask questions and retrieve information needed for their patient treatments without breaking sterile scrub.

April 1, 2019
·
2 min read
Biotech Beach

Prostate Cancer Foundation Ambassadors Harry Lennix, Chris Tucker, Randy Jackson, Rev. Rosey Grier, Brian Custer and Others Join Together to Raise Awareness About Prostate Cancer During National Minority Health Month

New PSA Starring Harry Lennix Urges African American Men to “Know the Numbers”

April 1, 2019
·
4 min read
Deals

Evolution Research Group Acquires Finger Lakes Clinical Research

FLCR has conducted trials across a broad range of illnesses, including anxiety disorders, ADHD, depression, bipolar disorder, schizophrenia and other mental illnesses since its founding in 2002.

April 1, 2019
·
2 min read
Biotech Beach

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Sponsors International Autistic Week in Ribeirao Preto, Brazil

HempMeds® Brasil will be sponsoring TEAbraco 2019 International Autism Week from April 1 to April 7 at the Iguatemi Mall in Ribeirão Preto, Brazil.

April 1, 2019
·
4 min read
Pharm Country

Citius Announces $5.3 Million Registered Direct Offering Priced At-the-Market

The closing of the offering is expected to occur on or about April 3, 2019, subject to the satisfaction of customary closing conditions.

April 1, 2019
·
5 min read
Pharm Country

Study Finds Vast Differences In Ease-Of-Use For Naloxone Delivery Methods

Full study evaluating two formulations of opioid reversal drug naloxone were published in Pain and Therapy

April 1, 2019
·
2 min read
FDA

FDA approves the reintroduction of Zelnorm™ (tegaserod) for Irritable Bowel Syndrome with Constipation (IBS-C) in women under 65

Zelnorm works differently than other prescription treatments for IBS-C by inducing intestinal contraction and relaxation.

April 1, 2019
·
7 min read